Literature DB >> 21542744

Sentinel-lymph-node biopsy for cutaneous melanoma.

Jeffrey E Gershenwald1, Merrick I Ross.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21542744     DOI： 10.1056/NEJMct1002967

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.

Authors:  Bo Li; Yanru Wang; Yinghui Xu; Hongliang Liu; Wendy Bloomer; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-01-17       Impact factor: 7.396

2.  Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial.

Authors:  Ingo Stoffels; Ken Herrmann; Jan Rekowski; Philipp Jansen; Dirk Schadendorf; Andreas Stang; Joachim Klode
Journal:  Trials       Date:  2019-02-04       Impact factor: 2.279

3.  Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Authors:  Paolo A Ascierto; Antonio M Grimaldi; Ana Carrizosa Anderson; Carlo Bifulco; Alistair Cochran; Claus Garbe; Alexander M Eggermont; Mark Faries; Soldano Ferrone; Jeffrey E Gershenwald; Thomas F Gajewski; Ruth Halaban; F Stephen Hodi; Richard Kefford; John M Kirkwood; James Larkin; Sancy Leachman; Michele Maio; Richard Marais; Giuseppe Masucci; Ignacio Melero; Giuseppe Palmieri; Igor Puzanov; Antoni Ribas; Yvonne Saenger; Bastian Schilling; Barbara Seliger; David Stroncek; Ryan Sullivan; Alessandro Testori; Ena Wang; Gennaro Ciliberto; Nicola Mozzillo; Francesco M Marincola; Magdalena Thurin
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

4.  Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival.

Authors:  Hua Yuan; Hongliang Liu; Zhensheng Liu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Qingyi Wei
Journal:  Int J Cancer       Date:  2015-01-28       Impact factor: 7.396

5.  Terahertz imaging of metastatic lymph nodes using spectroscopic integration technique.

Authors:  Jae Yeon Park; Hyuck Jae Choi; Hwayeong Cheon; Seong Whi Cho; Seungkoo Lee; Joo-Hiuk Son
Journal:  Biomed Opt Express       Date:  2017-01-25       Impact factor: 3.732

6.  Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.

Authors:  Hong Mu; Tiffany L Calderone; Michael A Davies; Victor G Prieto; Hua Wang; Gordon B Mills; Menashe Bar-Eli; Jeffrey E Gershenwald
Journal:  Am J Pathol       Date:  2012-03-30       Impact factor: 4.307

7.  Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.

Authors:  Weikang Zhang; Hongliang Liu; Jieyun Yin; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Yi Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2016-09-14       Impact factor: 7.396

8.  Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.

Authors:  Jieyun Yin; Hongliang Liu; Xiaohua Yi; Wenting Wu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Jiali Han; Qingyi Wei
Journal:  Pigment Cell Melanoma Res       Date:  2016-01-29       Impact factor: 4.693

9.  Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma.

Authors:  J R van der Vorst; B E Schaafsma; F P R Verbeek; R J Swijnenburg; M Hutteman; G J Liefers; C J H van de Velde; J V Frangioni; A L Vahrmeijer
Journal:  Br J Dermatol       Date:  2013-01       Impact factor: 9.302

10.  Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.

Authors:  Sojun Hoshimoto; Tatsushi Shingai; Donald L Morton; Christine Kuo; Mark B Faries; Kelly Chong; David Elashoff; He-Jing Wang; Robert M Elashoff; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.